CBP/p300-IN-24
CBP/p300-IN-24 is a selective CBP bromodomain inhibitor with an IC50 of 32 μM, showing selectivity over BRD4 BD-1 bromodomain. CBP/p300-IN-24 binds to the acetyl lysine binding pocket, forms hydrogen bonds with Asn1168 and a solvent-mediated hydrogen bond with Tyr1125, and forms hydrophobic interactions with Leu1120, Ile1122, and Val1174.
For research use only. We do not sell to patients.
- CAS No.: 56369-21-2
- Formula: C11H14N2O
- Molecular Weight:190.25
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
BRD4 BD1 220 μM (IC50) |
In Vitro
CBP/p300-IN-24 (compound 1) inhibits isolated BRD4 BD-1 bromodomain with an IC50 of 220 μM[1].
CBP/p300-IN-24 binds to the acetyl lysine binding pocket of the isolated CBP bromodomain, forming specific hydrogen bonding and hydrophobic interactions[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 56369-21-2
-
Molecular Weight 190.25
-
Formula C11H14N2O
-
SMILES
O=C1NC=2C=CC=CC2NC(C)(C)C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)